Top 10 Medical Device Angel Investors in Singapore in September 2025

Last updated: Sep 2025 A list of 10 angel investors that invest in Medical device startups based in Singapore. We rank investors based on the number of investments they made in Medical device companies from Singapore. We update this investor list every month.

Top 10 Medical Device Angel Investors in Singapore in September 2025

Investor	Medical Device Singapore investments
Frederik Vandermarlie	1
Binny Bansal	1
Avi Reichental	1
Matt Cutts	1
Johannes Hille	1
Jack Wang	1
Eric Urhane	1
Paul Buchheit	1
Feng Hu	1
Benjamin Boyer	1

Find investors that fund startups like yours. Automatically.

Our algorithm will find investors that invest in your industry, stage, and geography.

Investor list

Frederik Vandermarlie

Investment focus

Medical, Legal Tech, Health Care
Seed
Belgium, Singapore

Portfolio highlights

X-ZELL — Early, pain-free cancer cell detection
Henchman — Effortlessly find the clauses you’re looking for by applying our AI to your existing contracts.

Binny Bansal is an Indian software engineer and Internet entrepreneur. In 2007 he co-founded the e-commerce platform Flipkart with Sachin Bansal (not related) and was serving as the Chief Operating Officer until 11 January 2016 and was promoted to Chief Executive Officer. In January 2017 he was promoted to Group CEO of Flipkart. Binny is fromChandigarh and graduated from the Indian Institute of Technology Delhi with a degree in Computer Science and Engineering.

Investment focus

Software, Internet, E-Commerce
Seed, Series A, Funding Round
India, United States, Singapore

Portfolio highlights

Posha — With our smart kitchen robot, Julia, we are making home cooking great again! Find out more about our story, technology, and Julia herself.
Curefoods — Curefoods democratizes access to food on a sustainable basis. They focus on operations management for cloud kitchens and the online food ordering market.
RISA Labs — We exist for humanity 2Win. Pioneering BOSS [Business (Operating System) as Service]. Trusted by Top Oncologists, we serve mission critical enterprises. Transforming key operations with AI-driven discipline. Headquartered in Silicon Valley, RISA has offices across the globe.

Avi Reichental is the current Co-Founder & Chairman of ParaMatters. He previously worked at Singularity University as a Core Faculty.

Investment focus

Health Care, 3D Technology, Internet of Things
Seed, Angel
United States, Israel, Singapore

Portfolio highlights

NXT Factory — Development a groundbreaking beam delivery system, that converts a single laser into several million microlasers, without power degradation.
ParaMatters — Introducing 3D Printing Software that saves engineers time and effort by automating the process of creating conformal, single-zone lattices.
Centaur Analytics, Inc. — Centaur Analytics is a industrial data and IoT analytics platform for post-harvest quality monitoring.Centaur Analytics use data science and sensors to monitor and predict product quality and safety for grains, like malting barley, wheat, and other commodities.

Matt Cutts joined Google as a Software Engineer in January 2000. Before Google, he was working on his Ph.D. in computer graphics at the University of North Carolina at Chapel Hill. He has an M.S. from UNC-Chapel Hill, and B.S. degrees in both mathematics and computer science from the University of Kentucky.Matt wrote SafeSearch, which isGoogle's family filter. In addition to his experience at Google, Matt held a top-secret clearance while working for the Department of Defense, and he's also worked at a game engine company. He claims that Google is the most fun by far.Matt talks about webmaster-related issues on his

Investment focus

SaaS, Health Care, Software
Seed, Angel, Series A
United States, Canada, Mexico

Portfolio highlights

Unima — Unima is decentralizing rapid testing across industries by taking diagnostics out of the lab to the place these are needed the most to secure a timely diagnostic for everyone, anywhere.Unima is solving is the centralization of lab testing, which limits the access to a timely diagnostic for billions. Current technology for diagnostics is veryprecise and can detect almost any disease known, but the problem is these require labs with expensive equipment and specialized technicians making lab testing impossible to scale up to provide universal and timely access to diagnostics.To solve this problem Unima developed Find, a rapid testing technology platform for real time diagnostics which allows anyone to diagnose a disease directly where it is needed, without using lab equipment, with results in 15 minutes or less and at a very low cost. With Find anyone can have access to a timely diagnostic even in the most remote areas of the world.The Find platform uses shark antibodies modified with genetic engineering to detect disease biomarkers in blood, saliva, urine or water samples. These shark antibodies are used in microfluidic cards and generate a visual reactions when in contact with specific biomarkers of the disease to be tested. Then to evaluate the result of the test, a picture of the testing card is taken with the proprietary Xplora smartphone app which runs image analysis process and neural network algorithms to generate an inmediate result. Then this result,along with contextual information like geolocation, date and time, is sent to a cloud server where it can be used for real time disease tracking.
X-ZELL — Early, pain-free cancer cell detection
Meter Feeder — Easily pay for parking through MeterFeeder

Johannes Hille

Investment focus

Medical, Health Care, Biotechnology
Seed
Singapore

Portfolio highlights

X-ZELL — Early, pain-free cancer cell detection

Jack Wang

Investment focus

Fertility, Biotechnology, Medical Device
Seed
Singapore

Portfolio highlights

Hannah Life Technologies — We make Earth's best products and services for couples in their parenthood journey.

Eric Urhane

Investment focus

Software, Health Care, Biotechnology
Seed, Angel
United States, Mexico, Singapore

Portfolio highlights

Unima — Unima is decentralizing rapid testing across industries by taking diagnostics out of the lab to the place these are needed the most to secure a timely diagnostic for everyone, anywhere.Unima is solving is the centralization of lab testing, which limits the access to a timely diagnostic for billions. Current technology for diagnostics is veryprecise and can detect almost any disease known, but the problem is these require labs with expensive equipment and specialized technicians making lab testing impossible to scale up to provide universal and timely access to diagnostics.To solve this problem Unima developed Find, a rapid testing technology platform for real time diagnostics which allows anyone to diagnose a disease directly where it is needed, without using lab equipment, with results in 15 minutes or less and at a very low cost. With Find anyone can have access to a timely diagnostic even in the most remote areas of the world.The Find platform uses shark antibodies modified with genetic engineering to detect disease biomarkers in blood, saliva, urine or water samples. These shark antibodies are used in microfluidic cards and generate a visual reactions when in contact with specific biomarkers of the disease to be tested. Then to evaluate the result of the test, a picture of the testing card is taken with the proprietary Xplora smartphone app which runs image analysis process and neural network algorithms to generate an inmediate result. Then this result,along with contextual information like geolocation, date and time, is sent to a cloud server where it can be used for real time disease tracking.
X-ZELL — Early, pain-free cancer cell detection
Chirply — Chirply is a platform for crowd-sourcing & crowd-curating design. Chirply's mission is to build engagement, stickiness, and virality through crowd-sourcing design. Initially the company focused on the launch of a marketplace for crowd-sourced design for paper goods - an industry that hasn't been disrupted since the advent of theprinting press. Chirply then launched a B2B platform for crowd-sourced design for brands to help engage users and use design to make daily products inspiring.

Paul Buchheit co-founded social network aggregator FriendFeed, along with three other former Google employees. He is also an investor in FriendFeed and participated in a $5 million Series A round in February 2008.He was the 23rd employee at Google, where he created Gmail and implemented many of its innovative features. He developed the originalprototype of Google AdSense, and was responsible for Google's famous "Don't be evil" motto in a meeting.

Investment focus

Software, Health Care, E-Commerce
Seed, Series A, Angel
United States, Canada, India

Portfolio highlights

SiPhox Health — SiPhox Health brings comprehensive, at-home blood testing to your door! Take control of your disease risk and increase your healthspan today with affordable, convenient at-home blood testing. No lab visits, no appointments, no waiting in line.
Character.ai — Chat with millions of AI Characters on the #1 AI chat app. Where will your next adventure take you?
Perplexity — Perplexity is a search engine platform that uses artificial intelligence to provide large language models and search engines. The company's platform enables the development of beneficial artificial general intelligence, as well as an open-source environment that is accessible to the public, allowing clients to develop skills and knowledge inartificial intelligence.

Feng Hu

Investment focus

Communities, Mobile Apps, Health Care
Seed, Pre-Seed, Convertible Note
United States, India, Singapore

Portfolio highlights

Credy — Credy provides instant online loan at low interest rate. Apply now for personal loan, education loan, medical loan, credit refinancing or other loans.
DIVE - Dating With Games — DIVE-Dating With Gaming is a trendy dating and gaming app. It offers super interesting roleplay games that break the ice and that lead to deeper and more fun experiences between matches.
Audetemi Inc. — Audetemi makes it easy for enterprises to enable their business on mobile, and create a superior, and engaging customer experience. Audetemi One platform allows businesses to effectively engage their customers by seamlessly integrating traditional customer engagement platforms onto their smartphones.

Ben Boyer is a Managing Director of Tenaya Capital, and he has been a member of the Tenaya investment team since 2000.Previously, Ben was a member of Lehman Brothers' Technology Investment Banking group, where he was responsible for corporate finance and strategic advisory assignments.Ben holds an M.B.A. from Stanford Graduate Schoolof Business and a B.S. in human and organizational development from Vanderbilt University.